Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.54 |
| ▸ | MEN1 | O00255 | 6/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 3/20 | 0.52 |
| ▸ | NR4A1 | P22736 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | MYC | P01106 | 1/20 | 0.52 |
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.52 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10205946 | 0.81 | ALDH1A1 (0.69) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL17916172 | 0.79 | PTGS2 (0.44) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL17916173 | 0.79 | CYP1A2 (0.40) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL3970588 | 0.79 | GSK3A (0.47) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL17172442 | 0.78 | NOTUM (0.50) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL21363125 | 0.78 | ALDH1A1 (0.55) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL3547671 | 0.78 | ATM (0.46) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL9370346 | 0.78 | POLB (0.64) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL13543619 | 0.77 | MAPT (0.58) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL12799580 | 0.76 | PTGS2 (0.66) | MAPTALDH1A1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103756740-B | Vehicle methanol fuel corrosion-inhibitor for various metals | SHAANXI YCZL NEW ENERGY CO LTD | 2015-05-20 | — | — | CN | claimed |
| CN-119569634-A | Process for the preparation of N-substituted pyrrole compounds | 中国石油化工股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119570046-A | Modified metal organic framework material and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119570045-A | Copper-iron bimetallic MOFs material, preparation method and application thereof, and method for preparing N-substituted pyrrole compound | 中国石油化工股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-118184564-A | Method for synthesizing 2, 5-dimethyl-N-aryl pyrrole compound | 浙江工业大学 | 2024-06-14 | — | — | CN | disclosed |
| CN-117603119-A | Preparation of cation free radical-based gene delivery system and application thereof in pancreatic cancer treatment | 华南理工大学 | 2024-02-27 | — | — | CN | disclosed |
| CN-117603119-A | Preparation of cation free radical-based gene delivery system and application thereof in pancreatic cancer treatment | 华南理工大学 | 2024-02-27 | — | — | CN | disclosed |
| CN-112165936-B | beta-lactamase inhibitor | 国立大学法人东海国立大学机构 | 2023-11-28 | — | — | CN | disclosed |
| US-11746098-B2 | Proteasome activity enhancing compounds | PROTEOSTASIS THERAPEUTICS, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| US-11746098-B2 | Proteasome activity enhancing compounds | PROTEOSTASIS THERAPEUTICS, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| US-5274072-A | A 2-amine-containing methylene-2,5-dihydrofur-5-one | EASTMAN KODAK COMPANY (US) | 1993-12-28 | — | — | US | disclosed |
| US-4273713-A | ANTIULCER AND ANTISECRETORY AGENTS | STERLING DRUG INC. (US) | 1981-06-16 | — | — | US | disclosed |
| US-4248784-A | Pyrrole-3-acetamides | STERLING DRUG INC. (US) | 1981-02-03 | — | — | US | disclosed |
| US-4239687-A | 4-CARBOXAMIDES, 4-THIOCARBOXAMIDES, 4-NITRILES, ANTISECRETORY, ANTIULCER | STERLING DRUG INC. (US) | 1980-12-16 | — | — | US | disclosed |
| US-4140854-A | ANTISECRETORY, ANTIULCER | STERLING DRUG INC. (US) | 1979-02-20 | — | — | US | disclosed |
| US-RE29834-E | PREPARED FROM 4-SULFONYL-1,8-NAPHTHOLACTAMS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-11-14 | — | — | US | disclosed |
| US-4098797-A | ANTISECRETORY, ANTIULCER AGENTS | STERLING DRUG INC. (US) | 1978-07-04 | — | — | US | disclosed |
| US-4016174-A | USED IN PRESSURE SENSITIVE RECORD MATERIALS AND MANIFOLD MARKING SYSTEMS | NCR CORPORATION (US) | 1977-04-05 | — | — | US | disclosed |
| US-4008250-A | ANTISECRETORY, ANTIULCER | STERLING DRUG INC. (US) | 1977-02-15 | — | — | US | disclosed |
| US-3959310-A | BENZINDOLE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11746098-B2 | Proteasome activity enhancing compounds | PSMG3, PSMC1, PSMB11 | MAPT 1252/4885ALDH1A1 3630/4885KDM4E 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.